Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign - 09/11/20
Doi : 10.1016/j.jaad.2020.07.099
Carlos Gustavo Wambier, MD, PhD a, ⁎ 
, Sergio Vaño-Galván, MD, PhD b, John McCoy, PhD c, Suraj Pai, MD d, Rachita Dhurat, MD, PhD d, Andy Goren, MD c
, Sergio Vaño-Galván, MD, PhD b, John McCoy, PhD c, Suraj Pai, MD d, Rachita Dhurat, MD, PhD d, Andy Goren, MD c a Department of Dermatology, Alpert Medical School of Brown University, Providence, Rhode Island
b Dermatology Department, Ramón y Cajal Hospital, Madrid, Spain
c Applied Biology, Inc, Irvine, California
d Department of Dermatology, Lokmanya Tilak Municipal Medical College and Hospital Sion, Mumbai, India
∗Correspondence to: Carlos Gustavo Wambier, MD, PhD, Department of Dermatology, Rhode Island Hospital, 593 Eddy St, APC building, 10th Floor, Providence, RI 02903Department of DermatologyRhode Island Hospital593 Eddy St, APC building, 10th FloorProvidenceRI02903
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Graphical abstract |
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: Not applicable. |
|
| Reprints not available from the authors. |
© 2020
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 83 - N° 6
P. e453-e454 - décembre 2020 Retour au numéro
Article précédent
- Androgenetic alopecia in COVID-19: Compared to what?
- Benjamin A. Nanes
- Reply to “Medical students' ability to diagnose common dermatologic conditions in skin of color”
- Marina K. Ibraheim, Rohit Gupta, Misha Koshelev
Bienvenue sur EM-consulte, la référence des professionnels de santé.